Paper

Paper

Changelog Terms Privacy Issues Docs Support Foundation About

Bevacizumab in Combination With Oxaliplatin-Based Chemoth... | ResearchHub

Paper

Paper

Supporters

Support the authors with ResearchCoin

Journal

Journal of Clinical Oncology

Topics

Cancer Oncology

Internal Medicine

DOI

10.1200/jco.2007.14.9930

Changelog Terms Privacy Issues Docs Support Foundation About

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

0

Authors

Leonard Saltz

Leonard Saltz•Arié Figer•Jim Cassidy

Published

April 17, 2008

Abstract

To evaluate the efficacy and safety of bevacizumab when added to first-line oxaliplatin-based chemotherapy (either capecitabine plus oxaliplatin [XELOX] or fluorouracil/folinic acid plus oxaliplatin [FOLFOX-4]) in patients with metastatic colorectal cancer (MCRC).

Supporters

Support the authors with ResearchCoin

Journal

Journal of Clinical Oncology

Topics

Cancer Oncology

Internal Medicine

DOI

10.1200/jco.2007.14.9930